Q1 2025 Holdings
Filed 2025-05-15 | 45 holdings | $449.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Health Inc(HROW) | COM | 415858109 | $105.2M | 3,955,000 | 23.4% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $37.0M | 2,852,070 | 8.2% |
| Sanuwave Health Inc(SNWV) | COM | 80303D305 | $34.4M | 972,002 | 7.7% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $33.3M | 2,260,000 | 7.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $26.0M | 490,000 | 5.8% |
| Codexis Inc(CDXS) | COM | 192005106 | $25.6M | 9,500,000 | 5.7% |
| Immunome Inc(IMNM) | COM | 45257U108 | $23.9M | 3,550,000 | 5.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $21.1M | 535,000 | 4.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.9M | 1,975,000 | 3.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $11.7M | 1,595,000 | 2.6% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.7M | 395,000 | 1.9% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $7.4M | 1,730,000 | 1.6% |
| Ginkgo Bioworks Holdings(DNA) | Class A New | 37611X209 | $6.8M | 1,195,000 | 1.5% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $6.3M | $11,500,000 | 1.4% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $5.9M | 395,000 | 1.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.1M | 105,000 | 1.1% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $5.0M | 253,043 | 1.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.0M | 795,000 | 1.1% |
| Palvella Therapeutics Inc(PVLA) | COM | 697947109 | $4.8M | 172,357 | 1.1% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $4.7M | 4,287,415 | 1.1% |
| Anaptys BIO Inc(ANAB) | COM | 032724106 | $4.7M | 250,933 | 1.0% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $4.6M | $6,000,000 | 1.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.2M | 85,000 | 0.9% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $4.1M | 1,914,077 | 0.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $4.0M | 163,988 | 0.9% |
| Acelyrin Inc | COM | 00445A100 | $4.0M | 1,615,000 | 0.9% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $3.6M | 440,000 | 0.8% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $3.5M | 2,209,998 | 0.8% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.2M | 1,985,000 | 0.7% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $2.7M | 666,503 | 0.6% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $2.1M | 175,000 | 0.5% |
| Biodesix Inc | COM | 09075X108 | $2.0M | 3,225,000 | 0.4% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.0M | 300,000 | 0.4% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $1.8M | 250,000 | 0.4% |
| Optinose Inc(0OP) | COM NEW | 68404V209 | $1.8M | 193,039 | 0.4% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $1.5M | 1,175,000 | 0.3% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $1.5M | 375,000 | 0.3% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHRS CL A | G52694109 | $1.4M | 62,501 | 0.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.4M | 115,000 | 0.3% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.3M | 465,000 | 0.3% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $691.9K | 1,055,000 | 0.2% |
| Pepgen Inc(PEPG) | COM | 713317105 | $590.1K | 420,000 | 0.1% |
| Journey Medical Corp(DERM) | COM | 48115J109 | $409.0K | 69,323 | 0.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $218.5K | 190,000 | 0.0% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $92.1K | 110,571 | 0.0% |